STAT

Research is scarce on medication use in pregnant women. Experts are urging the government to fix that

An expert panel formed by Congress is urging the federal government to include more pregnant and lactating women in clinical trials.
Source: LOIC VENANCE/AFP/Getty Images

There’s very little research on whether medications are safe and effective in pregnant and lactating women, but an expert panel has ideas for how to close that information gap — and it’s calling on the federal government to take action in a new report that could stir change.

The sweeping report is the product of more than a year of public meetings by a task force formed by Congress in 2016 to study why so few women can get while pregnant and lactating. More than 6 million women are pregnant in the U.S. each year, and it’s estimated that more than 90 percent take at least one medication while pregnant or lactating. But few

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.

Related Books & Audiobooks